Objective: to identify lethality and mortality rates and, mortality risk factors in ventilator associated pneumonia (VAP) on 114 patients treated between 2000 and 2007. Method: Twenty five risk factors were analyzed, emphasizing age, gender, APACHE score, associated diseases, hypotension at intake, coma, hospitalization time, length of time of ventilation, emergency intubation, reintubation, previous antibiotics, and resistant microrganisms. Results: Lethality was 25.4 %, and mortality was 2.4 %. Association between lethality, and APACHE score was found (p: 0.04). Critical APACHE value was 22. Also, in early pneumonia, association between lethality and nasogastric tube (p: 0.01, I.C. 95 % 1.39-6.35) was found. No association with late pneumonia was found among mortality and clinical practices. Death's RR (relative risk) increase in following values with: previous neurological disease 2.7 (p: 0.15, IC 95 % 1.15-6.5), neurological coma RR 2 (p: 0.2, IC 95 % 0.54-7.53). Nevertheless, at multivariate analysis no mortality risk factors were identified. Fair association with time in ICU (p: 0.051 IC 95 % 0.99-1.17) and, male sex (p: 0.051, IC 95 % 0.99-6.72) was found. Conclusions: We observed multiple factors associated to mortality in VAP: use of nasogastric catheter, longer stay in ICU and male sex.

Case-control study for evaluation of cost and outcome of nosocomial surgical site infection in primary hip arthroplasty during a period of 5 years. Mean hospitalization time in the orthopedic service was 54 days for cases, and 13 days for control (p<0.05). Mean hospitalization time in Intensive Care Unit (ICU) was 1.1 days for cases. There were 0.83 post primary surgery interventions in cases, and a mean of 2.08 bacteriological cultures in each case. Controls didn't have hospitalizations in the ICU surgical reinterventions nor cultures necessary. The mean cost of infected patients was US $: 6,174.8. Mean cost in controls was US $: 2,354.7. The excess of cost due to infections was US $: 2,354.7 on the average. Outcomes in cases were: normal function 30.8%; moderate or serious sequelae 46.2%; death rate 15, 4%. The measured parameters contributed to raise case costs, and they caused an unsatisfactory outcome for two third of the patients.